Suggested Topics within your search.
Suggested Topics within your search.
- Cancer 1
- Gynecology 1
- Obstetrics 1
- Oncology 1
- Pediatric 1
- Pediatric Hematology 1
- Pediatric hematology 1
- methods 1
-
4581
-
4582
-
4583
-
4584
Magnifying Endoscopy with Narrow Band Imaging to Determine the Extent of Resection in Transoral Robotic Surgery of Oropharyngeal Cancer
Published 2014-01-01“…One of the most important factors for achieving success in TORS is the ability to determine the extent of resection during the procedure as the extent of resection in the laryngopharynx not only affects oncological outcomes but also directly affects swallowing and voice functions. …”
Get full text
Article -
4585
-
4586
TET2 cascade: a novel regulator of chromatin structure and leukaemogenesis
Published 2025-01-01Get full text
Article -
4587
-
4588
Chemokine family significance and prognostic value in colorectal cancer
Published 2025-01-01Get full text
Article -
4589
Correlation of HER2 expression and clinicopathological characteristics in patients with urothelial carcinoma in China
Published 2024-11-01“…HER2 expression was significantly associated with various clinical and pathological characteristics such as Eastern Cooperative Oncology Group (ECOG) performance status, history of cardiovascular disease, history of metabolic disorders, smoking, UC disease location, differentiation grade, pathological type, and tumor stage. …”
Get full text
Article -
4590
-
4591
-
4592
Identification of novel pQTL‐SNPs associated with lung adenocarcinoma risk: A multi‐stage study
Published 2024-09-01Get full text
Article -
4593
Pembrolizumab and Pemetrexed for Older Patients With Nonsquamous NSCLC and Programmed Cell Death-Ligand 1 Tumor Proportion Scores of Less Than 50%
Published 2025-03-01“…Eligible participants had metastatic or recurrent nonsquamous NSCLC without sensitizing EGFR or ALK alterations, were aged 75 years or above, had a programmed cell death-ligand 1 tumor proportion score of less than 50%, had not undergone systemic chemotherapy, and had an Eastern Cooperative Oncology Group performance status of 0 or 1. Patients received pemetrexed (500 mg/m2) and pembrolizumab (200 mg) on day 1 of each 21-day cycle. …”
Get full text
Article -
4594
-
4595
-
4596
-
4597
NALCN expression is down-regulated and associated with immune infiltration in gastric cancer
Published 2025-02-01Get full text
Article -
4598
Clinical characteristics and outcomes of patients with chondroblastoma undergoing surgery with various adjuvant procedures: a retrospective study of 59 cases
Published 2025-01-01“…Two patients received preoperative denosumab and neither experienced local recurrence nor functional impairments. Conclusions Good oncological and functional outcomes were achieved. Age < 17 years was associated with a high risk of local recurrence after curettage (P = 0.0198). …”
Get full text
Article -
4599
-
4600
Selective utilization of medicinal polysaccharides by human gut Bacteroides and Parabacteroides species
Published 2025-01-01Get full text
Article